Targeting Abeta phagocytosis by blocking IRAK-M innate immunity in Alzheimer mice

通过阻断阿尔茨海默病小鼠的 IRAK-M 先天免疫来靶向 Abeta 吞噬作用

基本信息

  • 批准号:
    8649898
  • 负责人:
  • 金额:
    $ 3.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-19 至 2015-09-18
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Alzheimer's disease (AD) is the most common dementia, and is hallmarked by deposition of A¿ peptides as 'senile' ¿-amyloid plaques, neuropathology, and neuroinflammation. Toll-like receptors (TLRs) are germline- encoded sensors of pathogens by cells of the innate immune system and play differential roles in amyloid homeostasis. TLRs transduce their signals through the serine/threonine IL-1 receptor-associated kinase (IRAK). The IRAK family is chiefly comprised of kinases that positively regulate TLR signaling, with the notable exception of the inhibitory kinase, IRAK-M. IRAK-M expression is specific to cells of monocytic lineage, including microglia, and plays a critical role in keeping innate immune responses in check. To test whether IRAK-M participated in cerebral amyloid remodeling, we crossed mice deficient in IRAK-M (IRAK-M-/-) with mice over expressing mutant human amyloid precursor protein, the APPPS1 mouse model of cerebral amyloidosis. We then evaluated the state of immune cell activation and cerebral A¿ burden in age and sex- matched littermates from three groups: APPPS1-IRAK-M+/+, APPPS1-IRAK-M-/+, and APPPS1-IRAK-M-/- mice. Preliminary data showed a gene dose-dependent effect where microglial activation inversely correlated with IRAK-M allele number. Further, brain parenchymal A¿ abundance was correspondingly attenuated in APPPS1- IRAK-M-/- mice as measured by biochemical approaches. Interestingly, confocal imaging of APPPS1- IRAK-M-/- mouse brains revealed A¿ colocalization with the lysosomal marker LAMP1, suggesting a phagocytic mechanism of IRAK-M-/- microglia-mediated A¿ clearance. This proposal is designed to test whether disinhibition of IRAK-M affects microglial remodeling of amyloid pathology. The focus of Specific Aim 1 will be to further characterize brain pathology and animal behavior in IRAK-M deficient Alzheimer mice. The proposed experiments will elucidate the impact of IRAK-M deficiency on the microglial response to Alzheimer- like pathology, including its influence on cognitive impairment. We will then evaluate cytokine/chemokine responses in vivo to determine the whether IRAK-M deficiency promotes pro- or anti-inflammatory reactions of microglia in APPPS1-IRAK-M-/- mice. Specific Aim 2 will further assess phagocytosis of A¿ in APPPS1-IRAK- M-/- microglia and determine the function of IRAK-M in A¿ phagocytosis. The applicant is a third-year doctoral student in the laboratory of Dr. Terrence Town, who has been working in the field of AD innate immunology for the past 17 years. The proposed training plan outlines a set of career development activities and scientific workshops - e.g. advanced education in neuropathology, animal behavior and grant writing - to facilitate completion of this work.
项目总结/摘要 阿尔茨海默病(AD)是最常见的痴呆症,其特征是A肽沉积, “老年性"-淀粉样斑块、神经病理学和神经炎症。Toll样受体(TLR)是生殖细胞系- 由先天免疫系统的细胞编码的病原体传感器,并在淀粉样蛋白中发挥不同的作用 体内平衡TLR通过丝氨酸/苏氨酸IL-1受体相关激酶传递信号 (伊拉克)。IRAK家族主要由正向调节TLR信号传导的激酶组成,其中显著的 抑制性激酶IRAK-M除外。IRAK-M表达特异于单核细胞谱系的细胞, 包括小胶质细胞,并在控制先天免疫反应方面发挥关键作用。来测试是否 IRAK-M参与脑淀粉样蛋白重塑,我们将IRAK-M缺陷小鼠(IRAK-M-/-)与 过表达突变型人淀粉样前体蛋白的小鼠,APPPS 1小鼠脑缺血模型, 淀粉样变性然后,我们评估了年龄和性别的免疫细胞活化状态和大脑A?负荷, 来自三组的匹配同窝出生的小鼠:APPPS 1-IRAK-M+/+、APPPS 1-IRAK-M-/+和APPPS 1-IRAK-M-/-小鼠。 初步数据显示基因剂量依赖性效应,其中小胶质细胞活化与 IRAK-M等位基因数。此外,在APPPS 1中,脑实质A?丰度相应地减弱。 IRAK-M-/-小鼠,通过生物化学方法测量。有趣的是,APPPS 1- IRAK-M-/-小鼠脑显示与溶酶体标记物LAMP 1共定位,表明 IRAK-M-/-小胶质细胞介导的A?清除的吞噬机制。该提案旨在测试 IRAK-M的去抑制是否影响淀粉样病变的小胶质细胞重塑。特定目标的焦点 1将进一步表征IRAK-M缺陷型阿尔茨海默病小鼠的脑病理学和动物行为。的 拟议的实验将阐明IRAK-M缺陷对阿尔茨海默氏症的小胶质细胞反应的影响, 比如病理学,包括它对认知障碍的影响。然后我们将评估细胞因子/趋化因子 在体内的反应,以确定是否IRAK-M缺陷促进促炎反应或抗炎反应, APPPS 1-IRAK-M-/-小鼠中的小胶质细胞。具体目标2将进一步评估APPPS 1-IRAK中A?的吞噬作用。 M-/-小胶质细胞,并确定IRAK-M在A?吞噬中的功能。申请人是三年级博士生 Terrence Town博士实验室的学生,他一直在AD先天免疫学领域工作, 过去的17年。拟议的培训计划概述了一系列职业发展活动和科学 研讨会-例如神经病理学,动物行为学和赠款写作的高级教育-以促进 完成这项工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Gate其他文献

David Gate的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Gate', 18)}}的其他基金

The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
  • 批准号:
    10674878
  • 财政年份:
    2022
  • 资助金额:
    $ 3.58万
  • 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
  • 批准号:
    10515592
  • 财政年份:
    2022
  • 资助金额:
    $ 3.58万
  • 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
  • 批准号:
    10054559
  • 财政年份:
    2020
  • 资助金额:
    $ 3.58万
  • 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
  • 批准号:
    10529475
  • 财政年份:
    2020
  • 资助金额:
    $ 3.58万
  • 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
  • 批准号:
    10207808
  • 财政年份:
    2020
  • 资助金额:
    $ 3.58万
  • 项目类别:
A novel blood-CSF adaptive immune response in Alzheimer's disease
阿尔茨海默病中一种新型的血液-脑脊液适应性免疫反应
  • 批准号:
    10545096
  • 财政年份:
    2020
  • 资助金额:
    $ 3.58万
  • 项目类别:
Reversing epigenetic changes in aged microglia via young circulatory factors
通过年轻循环因子逆转衰老小胶质细胞的表观遗传变化
  • 批准号:
    9812746
  • 财政年份:
    2018
  • 资助金额:
    $ 3.58万
  • 项目类别:
Targeting Abeta phagocytosis by blocking IRAK-M innate immunity in Alzheimer mice
通过阻断阿尔茨海默病小鼠的 IRAK-M 先天免疫来靶向 Abeta 吞噬作用
  • 批准号:
    8760213
  • 财政年份:
    2013
  • 资助金额:
    $ 3.58万
  • 项目类别:

相似海外基金

Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
  • 批准号:
    495182
  • 财政年份:
    2023
  • 资助金额:
    $ 3.58万
  • 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
  • 批准号:
    2601817
  • 财政年份:
    2021
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
  • 批准号:
    2029039
  • 财政年份:
    2020
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
  • 批准号:
    9888417
  • 财政年份:
    2019
  • 资助金额:
    $ 3.58万
  • 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
  • 批准号:
    17K11318
  • 财政年份:
    2017
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9320090
  • 财政年份:
    2017
  • 资助金额:
    $ 3.58万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    10166936
  • 财政年份:
    2017
  • 资助金额:
    $ 3.58万
  • 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
  • 批准号:
    9761593
  • 财政年份:
    2017
  • 资助金额:
    $ 3.58万
  • 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
  • 批准号:
    BB/M50306X/1
  • 财政年份:
    2014
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
  • 批准号:
    288272
  • 财政年份:
    2013
  • 资助金额:
    $ 3.58万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了